Vol. 276, Issue 6, E1171-E1193, June 1999
MODELING IN PHYSIOLOGY
Undermodeling affects minimal model
indexes: insights from a two-compartment model
Andrea
Caumo1,
Paolo
Vicini2,
Jeffrey J.
Zachwieja3,
Angelo
Avogaro4,
Kevin
Yarasheski5,
Dennis M.
Bier6, and
Claudio
Cobelli7
1 San Raffaele Scientific
Institute, 20100 Milan;
4 Department of Metabolic
Diseases and 7 Department of
Electronics and Informatics, University of Padova, 35131 Padua, Italy;
2 Department of Bioengineering,
University of Washington, Seattle, Washington
98195; 3 Pennington
Biomedical Research Center, Louisiana State University, Baton Rouge,
Louisiana
70808; 5 Metabolism
Division, Washington University School of Medicine, Saint Louis,
Missouri 63110; and
6 Children's Nutrition Research
Center, Baylor College of Medicine, Houston, Texas
77030-2600
 |
ABSTRACT |
The classic (hereafter cold) and the labeled
(hereafter hot) minimal models are powerful tools to investigate
glucose metabolism. The cold model provides, from intravenous glucose
tolerance test (IVGTT) data, indexes of glucose effectiveness
(SG) and insulin sensitivity
(SI) that measure the effect of
glucose and insulin, respectively, to enhance glucose disappearance and
inhibit endogenous glucose production. The hot model provides, from hot
IVGTT data, indexes of glucose effectiveness
(
) and insulin sensitivity (
) that, respectively, measure the
effects of glucose and insulin on glucose disappearance only. Recent
reports call for a reexamination of some of the assumptions of the
minimal models. We have previously pointed out the criticality of the
single-compartment description of glucose kinetics on which both the
minimal models are founded. In this paper we evaluate the impact of
single-compartment undermodeling on
SG,
SI,
, and
by using a two-compartment model
to describe the glucose system. The relationships of the minimal model
indexes to the analogous indexes measured with the glucose clamp
technique are also examined. Theoretical analysis and simulation
studies indicate that cold indexes are more affected than hot indexes
by undermodeling. In particular, care must be exercised in the
physiological interpretation of
SG, because this index is a local
descriptor of events taking place in the initial portion of the IVGTT.
As a consequence, SG not only
reflects glucose effect on glucose uptake and production but also the
rapid exchange of glucose between the accessible and nonaccessible
glucose pools that occurs in the early part of the test.
insulin sensitivity; glucose effectiveness; mathematical model; intravenous glucose tolerance test; glucose clamp
 |
INTRODUCTION |
THE INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT),
standard or modified with a tolbutamide or insulin injection,
interpreted with the classic minimal model of glucose disappearance
(hereafter cold minimal model) (6-10), is a powerful research tool
to investigate glucose metabolism in physiopathological and
epidemiological studies; more than 350 papers have appeared until 1998. The model provides two metabolic indexes measuring glucose
effectiveness (SG) and insulin
sensitivity (SI).
SG and
SI are composite parameters, i.e.,
they measure the overall effect of glucose and insulin, respectively,
to enhance glucose disappearance
(Rd) and inhibit endogenous
glucose production (EGP). To segregate the effect of glucose and
insulin on Rd and EGP, a labeled
(hereafter hot) IVGTT has been introduced, i.e., a glucose tracer has
been added to the glucose bolus (2, 17, 19, 23). The hot IVGTT
interpreted with a minimal model of labeled glucose disappearance
(hereafter hot minimal model) provides new indexes of glucose
effectiveness (
) and insulin
sensitivity (
) that measure the
effects of glucose and insulin, respectively, on glucose disposal only (19, 23).
Several investigators have recently reexamined some of the minimal
model assumptions (16-18, 22-24, 27, 30, 32). We have found
some unexpected relationships between the cold and hot
indexes (17, 19); in addition, we have
observed that when EGP is derived by combining the cold and hot minimal
models, its time course is physiologically absurd (17). Quon et al.
(30) have shown in a study on insulin-dependent diabetes mellitus
patients that SG is likely to be
overestimated. Saad et al. (32) have shown that
SI obtained from an
insulin-modified IVGTT is well correlated but markedly underestimated
compared with the insulin sensitivity index obtained with the glucose
clamp technique. Finegood and Tzur (24) have shown in dogs that
decreased SG associated with decreased insulin response is an artifact of the minimal model method
and that SG is poorly correlated
with the glucose effectiveness index obtained with the glucose clamp technique.
We have suggested two possible areas of model error (16, 18, 22, 23,
38): the monocompartmental structure of both the minimal models and the
description of EGP embodied in the cold minimal model. We have shown
that the monocompartmental structure is the major area responsible for
the implausible EGP profile and that a two-compartment hot minimal
model provides not only a reliable profile of EGP by deconvolution (14,
39) but also tracer-based indexes of glucose effectiveness, insulin
sensitivity, and plasma clearance rate (37). Recently, we have used the
two-compartment paradigm (18, 22, 38) to explain the findings of Quon
et al. (30) and Saad et al. (32) and the poor agreement between SG and the clamp-based index of
glucose effectiveness (24).
The aim of the present paper is to use a two-compartment model of
glucose metabolism to explain the mechanisms by which monocompartmental undermodeling affects both cold and hot minimal model indexes.
Glossary
A1, A2;
,
 |
Coefficients of two-exponential cold and hot glucose decay during an
IVGTT at basal insulin, mg/dl and dmp/ml (for a radiolabeled IVGTT)
|
| D, D* |
Cold and and hot glucose IVGTT dose, mg/kg and dpm/kg, respectively
|
| EGP(t) |
Endogenous glucose production,
mg · kg 1 · min 1
|
| EGPb |
Endogenous glucose production in the basal state,
mg · kg 1 · min 1
|
| g(t), g*(t) |
Cold and hot glucose concentration in plasma, mg/dl and dpm/ml,
respectively
|
| g(0), g*(0) |
Minimal model estimates of cold and hot glucose concentration at
time 0+, mg/dl and dpm/ml, respectively
|
| gb |
Plasma glucose concentration in basal state, mg/dl
|
g2(t),
*2(t) |
Cold and hot glucose concentration in the second pool of the
two-compartment model, mg/dl and dpm/ml, respectively
|
2(t),
*2(t) |
As above, with insulin-dependent removal moved to the accessible pool,
mg/dl and dpm/ml, respectively
|
| GE, GE* |
Cold and hot glucose effectiveness of the two-compartment
model,
ml · kg 1 · min 1
|
| GEb |
Cold glucose effectiveness measured from the area under the glucose
excursion during an IVGTT at basal insulin,
ml · kg 1 · min 1
|
| GINF(t) |
Glucose infusion rate during the glucose clamp,
mg · kg 1 · min 1
|
| k21, k12,
k02, kd, |
Rate parameters of the two-compartment model, min 1
|
| k22 |
k22 = k12+k02,
min 1
|
| ka |
Rate constant of the remote insulin compartment in the two-compartment
model, min 1
|
| kbd, kbp |
Parameters describing insulin effect on glucose uptake and EGP in the
two-compartment model,
min 2 · ml · µU 1,
respectively
|
| kp |
Parameter describing glucose effect on EGP in the two-compartment
model, min 1
|
| i(t) |
Insulin concentration in plasma, µU/ml
|
| ib |
Plasma insulin concentration in the basal state, µU/ml
|
| IS,IS* |
Cold and hot insulin sensitivity of the two-compartment model,
ml · kg 1 · min 1
per µU/ml
|
| PCRb |
Plasma glucose clearance in the basal state,
ml · kg 1 · min 1
|
p1, p2;
,
 |
Cold and hot minimal model rate parameters, min 1
|
qi(t),
(t) |
Cold and hot glucose mass in ith compartment of the
two-compartment model (i = 1, 2), mg and dpm, respectively
|
| Rd(t) |
Glucose disappearance rate from the accessible pool,
mg · kg 1 · min 1
|
| Rd,0 |
Nonzero intercept of the relationship Rd vs. g,
mg · kg 1 · min 1
|
SG,  |
Minimal model estimates of cold and hot glucose effectiveness,
min 1
|
| SG(clamp),SG,d(clamp) |
Glucose clamp measurements of cold and hot glucose effectiveness,
ml · kg 1 · min 1
|
SI,  |
Minimal model estimates of cold and hot insulin sensitivity,
min 1 · µU · ml 1
|
| SI(clamp),SI,d(clamp) |
Glucose clamp measurements of cold and hot insulin sensitivity,
ml · kg 1 · min 1 · µU 1 · ml
|
| t |
Time, min
|
| V,V* |
Cold and hot minimal model volume, ml/kg
|
| V1 |
Volume of the accessible pool of the two-compartment model, ml/kg
|
| VT |
Total glucose distribution volume, ml/kg
|
| x(t), x*(t) |
Cold and hot minimal model insulin action, min 1
|
| X(t) |
Two-compartment model insulin action, i.e., X = xp+xd,
min 1
|
(t) |
As above, with insulin-dependent removal moved to the accessible pool,
i.e., = xp + d, min 1
|
| xd(t) |
Two-compartment model insulin action on glucose uptake,
min 1
|
d(t),
(t) |
As above, with insulin-dependent removal moved to the accessible pool
(the asterisk denotes tracer-based calculation),
min 1
|
| xp(t) |
Two-compartment model insulin action on EGP, min 1
|
(t) |
Deviation of hot glucose decay from a two-exponential function during
an IVGTT at basal insulin, dpm/ml
|
 |
= k21k12,
min 2
|
1, 2;
,
 |
Fast and slow eigenvalues of the cold and hot glucose decay during an
IVGTT at basal insulin, min 1
|
 |
THE COLD AND HOT MINIMAL MODELS |
The Cold Model
The cold minimal model (Fig. 1) interprets
plasma glucose and insulin concentrations measured during an IVGTT
(standard, or modified with a tolbutamide or insulin injection). The
model in its uniquely identifiable parametrization (6, 8, 9, 23) is
described by
|
(1)
|
where g is plasma glucose concentration
(gb denotes its basal end test
value), i is plasma insulin concentration
(ib denotes its basal end test
value), D is the glucose dose in the bolus, V is the glucose
distribution volume, x is insulin
action [x = (k4+k6)i',
where i' is insulin in the remote compartment], and the
pi values are parameters related to
the ki values: p1 = k1+k5,
p2 = k3,
p3 = k2(k4+k6).
Parameters p1,
p2,
p3, and V can be
estimated from glucose and insulin data by use of nonlinear least
squares parameter estimation techniques (13). From them one can
calculate the cold indexes of glucose effectiveness,
SG, and insulin sensitivity,
SI, as
|
(2)
|
SG and
SI measure the effects of glucose
and insulin, respectively, on both
Rd and EGP. In fact, because
SG is a function not only of
k1, but also of
k5 (see Fig. 1),
it measures the ability of glucose at basal insulin to stimulate
Rd and to inhibit EGP. Similarly,
SI is a function not only of
k1,
k3,
k4, but also of k6, and thus
measures the ability of insulin to enhance the glucose stimulation of
Rd and inhibition of EGP.
Parameter p2 is
the rate constant of the remote insulin compartment and governs the
speed of rise and decay of insulin action.
Reference values for SG and
SI have been obtained from the
analysis of insulin and cold glucose data of a hot IVGTT performed in
25 normal young adults. Values for
SG and
SI were, respectively, 0.026 ± 0.002 min
1 and 7.3 ± 1.0 × 10
4
min
1 · µU
1 · ml.
The mean precision of SG and
SI estimates was 49 and 18%, respectively. Volume V was estimated as 1.66 ± 0.05 dl/kg.
The Hot Model
The hot minimal model (Fig. 2) interprets
plasma hot glucose and insulin concentrations measured during a hot
IVGTT, that is, an IVGTT (standard, or modified with a tolbutamide or
insulin injection) in which a glucose tracer (radioactive or stable
isotope) is added to the glucose bolus. Because hot glucose
concentration only reflects Rd,
the hot model yields indexes measuring glucose and insulin effect on
Rd only. The model in its uniquely
identifiable parametrization (2, 17, 19, 23) is described
by
|
(3)
|
where the symbols are the same as in Eq. 1, with the asterisk denoting tracer-related variables
and parameters. In particular, D* is the hot glucose dose, V* is the
hot glucose distribution volume, x* is
hot insulin action (proportional to remote insulin i'*,
x* = k4i'*), and
the
values
are parameters related to the
ki values:
= k1,
= k3, and
= k2k4.
Parameters
,
,
, and V* can be
estimated from insulin and hot glucose data by using nonlinear least
squares parameter estimation techniques (13). From them one can
calculate the hot indexes of glucose effectiveness,
, and insulin sensitivity,
, as
|
(4)
|
measures the ability
of glucose at basal insulin to stimulate
Rd, and
measures the ability of insulin
to enhance glucose stimulation of
Rd. Parameter
is the rate constant
of the remote insulin compartment and governs the speed of rise and
decay of hot insulin action.
Values for
and
have been obtained in the same 25 normal young subjects from the analysis of insulin and hot glucose data
of the hot IVGTT. Data on 15 subjects have already been reported in
previous publications (2, 17). Stable isotopes ([6-2H2]glucose
and [2-2H]glucose)
were employed in 19 studies, whereas a radioactive isotope
([3-3H]glucose) was
employed in 6 studies. Values for
and
were, respectively,
0.0082 ± 0.0003 min
1 and 9.0 ± 1.2 × 10
4
min
1 · µU
1 · ml.
The mean precision of
and
estimates was 4 and 5%,
respectively. Volume V* was estimated as 1.88 ± 0.06 dl/kg.
Cold vs. Hot Indexes
The results of this study confirm previously observed trends (2, 17,
19): SG is about three times
higher than
(P < 0.001), and
SI is lower than
(P < 0.05). Of note is that these
trends are also present when the indexes are estimated from an
insulin-modified hot IVGTT (unpublished results). Thanks to the larger
data base, it is now possible to assess the degree of correlation
between SG and
and between
SI and
(Fig.
3). Whereas a strong correlation exists
between SI and
(r = 0.84, P < 0.001),
SG and
are uncorrelated
(r = 0.17, P > 0.15).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 3.
Correlation between cold and hot indexes of glucose effectiveness
(A) and insulin sensitivity (B). See glossary
for definition of terms.
|
|
Some of the above results are unexpected and suggest the presence of
some model error. SG is higher
than
, in keeping with the
theoretical expectation, but their ratio is too high compared with that
of the analogous clamp-based indexes of cold, SG(clamp), and hot,
SG,d(clamp), glucose effectiveness
(subscript "d" denotes disappearance). In fact, whereas
SG is about three times higher
than
,
SG(clamp) is only 1.5 times higher than SG,d(clamp) (11). Also, the
complete lack of correlation between
SG and
is surprising, because
SG(clamp) and
SG,d(clamp) are presumably well
correlated, given that SG,d(clamp)
is the major determinant (~2/3) of
SG(clamp) (11).
The time courses of cold and hot insulin actions (Fig.
4) also show an unexpected trend. The cold
minimal model assumes that insulin actions on
Rd and EGP have the same timing,
but the time lag between x and
x* (caused by
p2 being lower
than
) violates this
assumption. In addition, the profile of insulin action on EGP,
calculated as the difference x
x*, is physiologically implausible
(17).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Cold and hot insulin action during a standard hot intravenous glucose
tolerance test (IVGTT) in a representative subject.
|
|
Finally, the finding SI <
is unexpected, because
SI, which measures insulin effect
on both Rd and EGP, should be
higher than
, which measures
insulin effect on Rd only. This
incongruity is not present when insulin sensitivity is assessed with
the glucose clamp technique: in Ref. 10
SI(clamp) exceeded
SI,d(clamp) [denoted as
SI,p(clamp) in that paper]
in each subject, with SI(clamp) and SI,d(clamp) being the clamp
version analogous to SI and
, respectively.
The above inconsistencies are symptoms of model error. Two possible
areas of error are the description of glucose and insulin effect on EGP
embodied in the cold model and the single-compartment description of
glucose kinetics (17, 18, 23). In this paper we focus on the latter only.
 |
A TWO-COMPARTMENT MODEL OF THE GLUCOSE SYSTEM DURING THE IVGTT |
To investigate the mechanisms by which single-compartment undermodeling
affects the minimal model indexes, we developed a physiologically based
two-compartment model to describe the glucose system during the IVGTT.
The model, shown in Fig. 5, is described in
detail in APPENDIX A. Briefly, the
model describes both glucose kinetics and EGP during the IVGTT. The
description of glucose kinetics is the same as that of the
two-compartment minimal model proposed in Refs. 14 and 37. It is
assumed that insulin-independent glucose disposal occurs in the
accessible compartment, whereas insulin-dependent glucose disposal
occurs in the nonaccessible compartment. Consistent with known
physiology, insulin-independent glucose uptake accounts for the
inhibitory effect of hyperglycemia on glucose clearance. It consists of
two components, one constant and the other proportional to glucose concentration. Insulin-dependent glucose uptake is parametrically controlled by insulin in a remote insulin compartment. The assumption is made that, in the basal state, insulin-dependent glucose disposal is
three times insulin-independent glucose disposal. EGP is described using the same functional description embodied in the cold minimal model (8, 17, 19, 23), thus allowing us to focus on the bias due to
single-compartment undermodeling only. In fact, EGP inhibition is
assumed to be proportional to the increment of glucose concentration
above basal and to the product of glucose concentration and insulin
action. In addition, as in the minimal model, insulin action on EGP is
assumed to have the same timing as insulin action on glucose uptake.
To ascertain the ability of this model to describe satisfactorily the
glucose system during the IVGTT, we used Monte Carlo simulation
(details in APPENDIX B). Briefly,
the two-compartment model with mean parameters was used to generate
noise-free cold and hot glucose data during a hot IVGTT. The mean
insulin profile of either a standard or an insulin-modified IVGTT was
used as input to the model. Noise of appropriate characteristics was
added to the data, and the noisy IVGTT data sets were then interpreted with the minimal models. We reasoned that, if the two-compartment model
is a realistic representation of the glucose system during the IVGTT,
the minimal model parameters estimated from the simulated data should
be close to those estimated from real data and should exhibit the same
trends discussed above. In addition, the relationships between the
minimal model estimates of glucose effectiveness and insulin
sensitivity and the analogous two-compartment model indexes should be
similar to those observed experimentally between the minimal model and
clamp-based indexes. These hypotheses were all confirmed. Table
1 reports the mean results of the
identification of the two minimal models from simulated IVGTT data. The
values of SG,
SI,
, and
are similar to those reported in
the literature. In particular, SI
is close to the value found by Saad et al. (32) in normal
subjects. This similarity is
noteworthy, because the insulin sensitivity of the two-compartment model has been chosen equal to the one found by Saad et al. in normal
subjects with the clamp technique (see APPENDIX
A). Of note is that all the experimentally observed
inconsistencies between cold and hot parameters are present:
SI is lower than
,
SG is twice
, and hot insulin action is faster than cold because
> p2 (e.g., for the
simulated standard IVGTT,
= 0.069 vs.
p2 = 0.027 min
1).
View this table:
[in this window]
[in a new window]
|
Table 1.
Monte Carlo simulation results: cold and hot minimal model indexes
estimated from standard and insulin-modified IVGTT
|
|
How do the minimal model indexes of glucose effectiveness and insulin
sensitivity compare with the "true" indexes of the
two-compartment model? To answer this question we derived indexes of
glucose effectiveness, insulin sensitivity, and basal plasma clearance
rate for the two-compartment model (details are provided in
APPENDIX C). Of note is that these
indexes are expressed in the same units as those of the corresponding
clamp-based indexes. To express also the minimal model indexes in the
same units, SG and
SI were multiplied by V, and
and
were multiplied by V*, in keeping
with the analysis reported in Vicini et al. (37). The values of the two-compartment and minimal model indexes are reported in Table 2. One can see that the cold minimal model
overestimates glucose effectiveness and underestimates insulin
sensitivity, in keeping with the experimental results (24, 32).
V* slightly underestimates basal
glucose clearance and markedly overestimates hot glucose effectiveness,
in keeping with the trend observed in Ref. 37. Specifically,
is virtually identical to the
basal fractional glucose clearance of the two-compartment model (e.g.,
from the standard IVGTT is 0.0102 min
1, and
PCR/VT = 0.0096 min
1). This is consistent
with the results of the
validation study in dogs (19).
V*
slightly underestimates the hot insulin sensitivity of the
two-compartment model, but no studies are available in the literature
comparing the hot minimal model insulin sensitivity with the analogous
clamp-based index.
View this table:
[in this window]
[in a new window]
|
Table 2.
Cold and hot glucose effectiveness and insulin sensitivity and basal
plasma clearance rate for 2-compartment model and minimal models
during a standard and an insulin-modified IVGTT
|
|
All in all, these results support the notion that the two-compartment
model is a satisfactory representation of the glucose system during the
IVGTT. We can thus use this model with confidence to analyze the impact
of monocompartmental undermodeling on the cold and hot minimal model
indexes and elucidate their relationships with the analogous
clamp-based measures of glucose effectiveness and insulin sensitivity.
 |
COLD GLUCOSE EFFECTIVENESS |
Effects of Monocompartmental Undermodeling on
SG
To examine the effects of the monocompartmental approximation on
SG, we build on Ref. 18 and, for
the sake of clarity, we outline the reasoning followed in that paper.
Usually, SG is estimated from an
IVGTT in which an insulin response is present and glucose decay depends
on both glucose and insulin. However, the effects of the
monocompartmental approximation on
SG can be more easily determined
if one first analyzes what happens during an IVGTT in which insulin is
maintained at the basal level. Under these conditions, insulin action
is identically equal to zero (Eq. 1), and the minimal model is described by a
first-order linear differential equation
|
(5)
|
Solving Eq. 5 for glucose concentration
and defining
g(t) = g(t)
gb, one has
|
(6)
|
Thus
the minimal model predicts that the decay of glucose concentration
during an IVGTT at basal insulin is monoexponential, with
SG as rate constant. The
fractional decay rate of incremental glucose concentration
(kG,
min
1), namely the
fraction of glucose concentration above basal that declines per unit
time, is constant and equal to SG
|
(7)
|
The true glucose system, however, is not monocompartmental. Using the
two-compartment model presented in the previous section, one can show
(APPENDIX D) that glucose decay
during an IVGTT at basal insulin is described by two exponentials
|
(8)
|
where
1 and
2
(min
1) are the fast and
slow components of glucose decay, respectively
(
1 >
2). Because of the presence of two time constants, the fractional decay rate of incremental glucose
concentration is no longer constant, but time varying
|
(9)
|
In
particular,
kG(t)
is higher at the beginning of the IVGTT, when the fast component of
glucose decay (
1) plays an
important role, and lower at the end of the IVGTT, when only the slow
component (
2) remains in play.
We compared the glucose decay curves and the fractional decay rates of
incremental glucose concentration predicted by the two-compartment and
the minimal models, using for the two-compartment model the parameters
of Table A1, and for the minimal model the SG and V values reported in Table
2. Figure 6 shows the glucose decay curves
(A) and the fractional decay rates
of incremental glucose concentration
(B) predicted by the two models. The
monoexponential decay curve predicted by the minimal model and the
two-exponential profile generated by the two-compartment model are
almost superimposable in the period of minutes
10-20 of the IVGTT but diverge thereafter, thus
reproducing closely the experimental observations by Quon et al. (30).
Of note is that the value of SG
(0.021 min
1) lies between
the values that
kG takes on
between 10 and 20 min [e.g.,
kG
(minute 15) = 0.023 min
1]. These results
suggest that the validity of SG as
descriptor of the effect of glucose per se is confined to the initial
portion of the IVGTT. The local validity of
SG is probably related to the fact
that, during an IVGTT with a normal insulin response, SG estimation critically depends
on the glucose data collected in the early portion of the IVGTT, when
glucose concentration is high over the baseline and insulin action,
albeit increasing, is still low (20). Because in that part of the test
both components of glucose decay are active,
SG not only reflects glucose
effects on Rd and EGP but also the
rapid exchange of glucose between the accessible and the nonaccessible
compartments occurring in the early part of the test.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Comparison between the two-compartment and the cold minimal model
predictions of glucose concentration
(A) and fractional decay rate of
incremental glucose concentration
(kG,
B) during an IVGTT at basal insulin.
The value of SG estimated during
an IVGTT with a normal insulin response is close to the value of
kG in the initial
portion of the test, approximately between 10 and 20 min.
|
|
Validation of SG
Validation of SG entails its
comparison with the analogous index measured with the glucose clamp
method, SG(clamp). In comparing SG with SG(clamp), one
is faced with the problem that such indexes have different units:
SG is expressed in
min
1, whereas
SG(clamp) is expressed in
ml · kg
1 · min
1.
As previously suggested in Ref. 17, to convert them to a common unit
one has to multiply SG by the
minimal model volume of glucose distribution, V. The correctness of
this approach has been formally demonstrated in Refs. 16 and 37. Of
note is that V emerges from the minimal model method and can be
individualized in each subject. In addition, multiplication of
SG by V parallels the approach
used in the validation studies of
SI (10, 32).
The value of SGV found
experimentally in the present study (4.2 ml · kg
1 · min
1)
is much higher than the value of
SG(clamp) in normal subjects that
can be found in the literature (2.4 ml · kg
1 · min
1
in Ref. 11). The same trend is observed if the value of
SGV obtained from our Monte Carlo
study is compared with the glucose effectiveness index of the
two-compartment model (see Table 2). The reason for
SGV being almost twice
SG(clamp) is that
SG and SG(clamp) reflect different
combinations of the fast and slow components of glucose disappearance
at basal insulin,
1 and
2. We have shown that
SG reflects the values that
kG takes on
between 10 and 20 min. Thus, from Eq. 9, one has
|
(10)
|
where
t0 is ~15 min
in subjects with a normal insulin response. Equation 10 shows that SG
is influenced by both the fast and slow components of glucose
disappearance. To compare quantitatively SGV with
SG(clamp), it is useful to express
SG as a function of
2 only. By exploiting the fact
that
A1
1e
1t0
2A2
2e
2t0
and
A2e
2t0
6A1e
1t0
(the values of
A1,
A2,
1, and
2 reported in Table D1), one
has
|
(11)
|
SG(clamp)
is measured from a hyperglycemic glucose clamp in which somatostatin is
used to suppress the endogenous insulin release, and the baseline
insulin is replaced by an exogenous insulin infusion (11). By applying
the formal definition of glucose effectiveness reported in
Eq. C1 to a hyperglycemic clamp at
basal insulin, one finds that
SG(clamp) is defined as the ratio of
(Rd
EGP) to the
increment in plasma glucose concentration at steady state. Given that
in the hyperglycemic steady state the increment in the exogenous
glucose infusion rate,
GINF, equals
(Rd
EGP),
SG(clamp) is defined as follows
|
(12)
|
Using
the two-compartment model to describe the glucose system during the
clamp, one can express SG(clamp)
as a function of the parameters of the model and, specifically, of the
two components of glucose disappearance at basal insulin (see
derivation in APPENDIX E)
|
(13)
|
It is easy to show that
SG(clamp) is primarily determined
by the slow component of glucose disappearance. In fact,
A2/
2
18A1/
1,
and thus SG(clamp)
2/A2.
Moreover, because
1/A2 approximates
the total glucose distribution volume
VT (28), and
VT
1.3 V (see Tables 1 and
A1), we can write
|
(14)
|
By comparing Eqs. 11 and 14, one realizes why
SGV is about twice
SG(clamp). It is worth pointing
out that SGV and
SG(clamp) are not only
quantitatively, but also qualitatively different; SGV also reflects, in addition to
glucose effect on Rd and EGP [measured by
SG(clamp)], the exchange
process taking place between the two glucose compartments in the early
part of the IVGTT. As a consequence, the correlation between these two
indexes is unlikely to be strong, as suggested by the simulation
studies reported in Refs. 22 and 38.
Finegood and Tzur have compared SG
with SG(clamp) in dogs (24). To
allow the comparison, the authors divided
SG(clamp) by the total volume of
glucose distribution, VT, taken
from the literature (250 ml/kg). They found that
SG was higher than the ratio of
SG(clamp) to
VT and that such indexes were
poorly correlated. These findings seem to support the notion that
SG and
SG(clamp) reflect different aspects of glucose effect per se. However, as we pointed out in Ref.
16, using VT to convert
SG(clamp) to the same units as SG is questionable because, as we
have discussed, the minimal model yields an index of glucose
effectiveness, SGV, that has the
same units of SG(clamp) and hinges
on a volume that, in contrast to a mean value of
VT, can be individualized in each subject.
SG from an IVGTT at Basal Insulin
It is commonly believed that SG
estimated from an IVGTT at basal insulin is a reliable measure of
glucose effectiveness, because under such conditions glucose is the
only determinant of glucose decay. However, even under these optimized
conditions, the validity of SG is
uncertain because the minimal model forces a monoexponential function
to describe a two-exponential decay. To determine whether SG estimated from an IVGTT at
basal insulin is a valid measure of glucose effectiveness, it is useful
to recognize that, under such experimental conditions, a minimal
model-independent index of glucose effectiveness can be calculated
directly from the area under glucose decay. In fact in Ref. 4 we showed
that whenever insulin concentration is maintained at the basal level
and exogenous glucose forces glucose to increase and return to the
baseline, glucose effectiveness at basal insulin, denoted as
GEb in Ref. 4, is given by the
ratio between the administered amount of glucose and the area under the
curve of the glycemic excursion above baseline [AUC(
g)].
In the case of an IVGTT at basal insulin, with the assumption that
glucose decay follows the two-exponential profile of
Eq. 8,
GEb is given by
|
(15)
|
Note
that the expression of GEb in
Eq. 15 coincides with that of
SG(clamp) in Eq. 13, in keeping with the analysis carried out in Ref. 4
that ascertained the theoretical equivalence of these two measurements
of glucose effectiveness. In that study (4), insulin was maintained at
the basal level and glucose excursion was similar to that observed
during a meal. Under those circumstances,
SGV resulted in a value similar to
GEb. It is presently unknown
whether this also holds for an IVGTT at basal insulin, because during
such an experiment the glucose profile is less smooth than during a
meal, and the minimal model is unable to account for the rapid fall of
glucose immediately after the glucose bolus. Nevertheless, some
observations can be made. We have seen previously that, during an IVGTT
with a normal insulin response, glucose decay reflects both glucose
effectiveness and insulin action, and
SG is mainly estimated from the
glucose data collected in the initial part of the IVGTT, when insulin
action is still low. During an IVGTT at basal insulin, insulin action
is null throughout the test, and glucose decay is governed by glucose effectiveness only. As a result, all of the glucose data between 10 min
and the end of the test contribute to
SG estimation. Because the
contribution of the fast component of glucose disappearance,
1, soon becomes negligible
(e.g., after ~30 min in normal subjects), and most of the glucose
data are beyond that point in time,
SG will approach the slow
component of glucose disappearance,
2, and the minimal model volume
will approach the reciprocal of
A2. Therefore,
SGV is approximated by
|
(16)
|
Comparison
of Eq. 16 with Eqs.
10 and 11 sheds some
light on the reasons why the value of
SG obtained from an IVGTT at basal insulin has been found to be lower than that obtained from an insulin-modified IVGTT (24): whereas the
SG estimated during an
insulin-modified IVGTT reflects both the fast and slow components of
glucose disappearance, the SG
estimated from an IVGTT at basal insulin reflects primarily the slow
component. Comparison of Eqs. 15 and 16 indicates that, during an IVGTT at
basal insulin, SGV will be close
to GEb if
A2/
2
>>
A1/
1.
Because
A2/
2
18A1/
1, it is likely that SGV estimated
from an IVGTT at basal insulin is a reliable estimate of glucose effectiveness.
SG measured from an IVGTT at basal
insulin has been compared with
SG(clamp) in dogs by Finegood and
Tzur (24). They found similar values for
SG and
SG(clamp) but no correlation
between them. Whereas the agreement between the mean values of the two indexes is consistent with the above analysis, the absence of correlation between them is surprising. In fact, this would mean that
the minimal model is not able to accurately assess glucose effectiveness, even when the IVGTT is performed at basal insulin. As
pointed out in Ref. 16, one possible explanation for this finding is
the relatively narrow range of glucose effectiveness observed in the
group of dogs examined in that study. Another possible explanation is
related to the fact that, at the end of the IVGTT studies carried out
at basal insulin, glucose concentration was below the pretest level and
still declining. This outcome may be due to the difficulty of obtaining
a stable baseline for glucose concentration with the combined
somatostatin, glucagon, and insulin infusion protocol. Alternatively,
it could be the symptom of an inaccurate description of EGP in the
minimal model. In fact, the model assumes that any change in glucose
concentration is accompanied by a proportional and opposite change in
EGP. The time course of EGP during an IVGTT at basal insulin is thus
expected to mirror that of glucose concentration. However, the finding that at the end of the IVGTT glucose concentration was below the pretest level and still declining suggests that EGP was still inhibited
at that time, implying that the minimal model description is not
correct. This model inadequacy may have affected the accuracy of
SG and worsened its concordance
with SG(clamp).
 |
COLD INSULIN SENSITIVITY |
Effects of Monocompartmental Undermodeling on
SI
The monocompartmental approximation also influences the minimal model
estimates of insulin action and sensitivity. As shown in Ref. 18,
because the model has to compensate for
SG overestimation and fit the
glucose data, insulin action is underestimated approximately until
glucose returns to the baseline and is overestimated thereafter. This
bias also affects SI, because this
parameter can be expressed as the ratio between the AUCs of insulin
action and insulin concentration above basal level (18). Here we build
on that paper and analyze the bias affecting the minimal model insulin
action and SI by comparing them
with the insulin action and sensitivity of the two-compartment model.
In carrying out this comparison, one must bear in mind that the cold
model insulin action,
x(t),
represents the sum of the insulin effects on glucose uptake and
production. In the two-compartment model,
xd(t)
is insulin action on glucose uptake, and
xp(t)
is insulin action on production. Thus
X(t) = xp(t)+xd(t)
represents exactly what
x(t)
represents for the minimal model. The profiles of
X(t)
and
x(t)
during a standard IVGTT are compared in Fig.
7A.
X(t)
was generated using the two-compartment model parameters reported in
Table A1;
x(t)
was generated using the mean parameters
SI and
p2 estimated with
the Monte Carlo simulation described in APPENDIX
B (SI = 2.9 × 10
4
min
1 · µU
1 · ml
and p2 = 0.027 min
1). It can be seen
that the minimal model markedly underestimates insulin action during
the first half of the test and slightly overestimates it thereafter. It
must be recognized, however, that this bias originates not only from
the different model order (one vs. two pools) but also from the
different location of insulin action on glucose uptake (accessible vs.
nonaccessible pool). To single out the effect of monocompartmental
undermodeling per se, we calculated in APPENDIX
F the effect that
xd(t) produces on the accessible pool of the two-compartment model. We termed
this effect as
(t).
(t) = xp(t) +
d(t)
is therefore the "accessible-pool equivalent" insulin action of
the two-compartment model that produces the same effect as
X on plasma glucose concentration (i.e., the accessible-pool Rd
remains the same).
(t)
is shown in Fig. 7B plotted against
the insulin action of the minimal model. Qualitatively speaking,
(t)
is a delayed and blunted version of
X(t).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7.
A: comparison between insulin action
of the two-compartment and the cold minimal models during a standard
IVGTT. B: insulin action of the
two-compartment model, which, if applied to the accessible pool, would
produce the same effect on glucose concentration as the one taking
place in the nonaccessible pool. This "accessible-pool
equivalent" profile of the two-compartment insulin action is
contrasted with the cold minimal model insulin action.
C: difference between
insulin action profiles of B is the
effect of monocompartmental undermodeling on cold minimal model i |
|